Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

TEPF:GR

33.5400 EUR 0.7800 2.27%

As of 13:38:56 ET on 04/17/2015.

Snapshot for Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund (TEPF)

Open: 34.3200 High - Low: 35.3100 - 33.5400 Primary Exchange: Stuttgart
Volume: 120 52-Week Range: 15.8300 - 36.2300 Beta vs NBI: 1.0051

ETF Chart for TEPF

No chart data available.
  • TEPF:GR 34.9100
  • 1D
  • 1M
  • 1Y
34.3200
Interactive TEPF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TEPF

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equity securities of biotechnology companies and discovery research firms, located in the US and other countries (with market capitalisation of less than $2 billion).

Inception Date: 2000-04-03 Telephone: 352-46-66-67-1
Managers: EVAN MCCULLOCH / JEREL BANKS
Web Site: www.franklintempleton.lu

Fundamentals for TEPF

NAV -
Assets (M) (on 2015-02-27) 2,865.4900
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for TEPF

No dividends reported

Performance for TEPF

1-Month -2.81% 1-Year +106.15%
3-Month +20.30% 3-Year +51.87%
Year To Date +28.41% 5-Year +36.14%
Expense Ratio 1.81

Top Fund Holdings for TEPF

Filing Date: 01/31/2015
Name Position Value % of Total
Celgene Corp 2,194,400 261,484,704 9.559%
Biogen Inc 554,740 215,882,618 7.892%
Gilead Sciences Inc 1,726,600 180,999,478 6.617%
Amgen Inc 834,500 127,060,970 4.645%
Medivation Inc 819,900 89,221,518 3.262%
Puma Biotechnology Inc 406,400 85,782,912 3.136%
BioMarin Pharmaceutical Inc 840,609 81,673,570 2.986%
Regeneron Pharmaceuticals Inc 194,200 80,915,372 2.958%
Illumina Inc 411,200 80,262,128 2.934%
Incyte Corp 927,700 73,946,967 2.703%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil